September 8, 2017
Arunthari V, Waller EA, Fredrickson PA, et al. Mayo Foundation for Medical Education and Research, 2010.
September 8, 2017
Scott DR, Simon RA. The Journal of Allergy and Clinical Immunology: In Practice. 2015;3(3):356-361.
September 7, 2017
Francis DO, Rymer JA, Slaughter JC, et al. Am J Gastroenterol. 2013;108(6):905-11.
September 7, 2017
Chheda NN, Seybt MW, Schade RR, Postma GN. Ann Otol Rhinol Laryngol. 2009 Mar;118(3):166-71.
May 30, 2017
Mederi Therapeutics announced highlights of educational activities on Stretta Therapy for Gastroesophageal Reflux Disease (GERD) that took place at Digestive Disease Week® 2017 (DDW 2017). The activities included a presentation on "Unmet Needs in GERD Treatment", presented by Dr. Ronnie Fass and Professor Jan Tack. The presentation featured data from the new Stretta Meta-Analysis as well as data on mechanism and GERD outcome measures.
June 13, 2016
Mederi Therapeutics, Inc., manufacturers of Stretta Therapy for GERD, today announced that a new study, published in Managed Care, suggests the potential for substantial payer cost savings associated with radiofrequency energy (RFE) treatment of GERD patients, as compared to treatment with medical management or fundoplication.
June 13, 2016
Stretta clinical data presented at DDW2016 shows effectiveness in challenging GERD patient populations: Obese patients, laryngopharyngeal reflux (LPR) symptoms, GERD post-nissen. DDW activities also included the launch of the new Stretta RFT3 system and four presentations by international Stretta expert physicians.
May 17, 2016
Mederi Therapeutics today announced a new multi-center registry that will study the benefit of Stretta Therapy as a treatment option in patients who experience gastroesophageal reflux disease (GERD) after sleeve gastrectomy (SG).
April 15, 2016
Get #GERDSmart!
It's time to Get Smart About GERD and help spread the word about the link between chronic reflux and Esophageal Cancer!